Health Canada has approved Mettrum’s request to produce cannabis extracts. The supplemental license, which allows the company to produce oils and resin, will be effective immediately.

“This furthers our commitment to provide physicians and their patients with alternative and convenient consumption methods,” said Mettrum President and CEO Michael Haines. “For people who use cannabis for their health, Mettrum is committed to helping them live their way by providing consistent high quality products, best-in-class service, and educational tools for our clients and the medical community.”

However, Mettrum must still wait for an amendment from Health Canada before they are able to ship their products to consumers.

 

Footnote(s)